Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
group studies the fundamental principles of embryonic neuronal development by combining genomics, gene editing, and bioinformatics. We offer an international, dynamic, and supportive research
-
multidisciplinary technical community across the Faculty of Medical Sciences, overseen by the technical manager. The technician work as part of a team to implement gene editing techniques to investigate
-
Intellia Therapeutics is a Cambridge-based biotechnology company focused on developing clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies to transform lives of
-
, quality control and release of transformation vectors and genome editing reagents for gene edited and transgenic crop programme. The successful candidate will be a technical authority in commercial
-
characterization techniques, proficiency in molecular biology techniques, including PCR, Western blotting, immunofluorescence, and flow cytometry, familiarity with gene editing tools (e.g., CRISPR/Cas9
-
Royal Netherlands Academy of Arts and Sciences (KNAW) | Wageningen, Provincie Gelderland | Netherlands | about 2 months ago
project at NIOO-KNAW), with genomic and epigenomic editing that identifies genes regulated by DNA methylation and tests the causal effects of candidate epialleles on gene expression (PhD project at UU
-
, primary metabolism, technology development, transgenic biology, genome editing, AI, and large-scale data analysis is desirable. Key Responsibilities Conduct soybean research involving gene knockout/KO
-
validation assays with guidance as needed. • Assist with gene manipulation workflows, including CRISPR/Cas9 editing and validation, and learn new molecular approaches required for ongoing projects
-
culture. · CRISPR /Cas genome editing. · Developmental or cellular disease models. · RNA biology. · Gene-expression or transcriptional regulation. · Noncoding
-
development of scalable gene editing platform to engineer therapeutic T cells for clinical trials in inherited disorders. This post will form part of a large, international, collaborative effort focused